S

    Seer Inc (SEER)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.96
    -0.02 (-1.01%)

    Market Cap: $109.64M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(16/24)
    Avg Surprise
    +4.06%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.24
    Range$-0.25 - $-0.23
    2 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.31-29.2%
    60d ago$-0.26-8.3%
    30d ago$-0.26-8.3%
    7d ago$-0.28-14.6%
    Current$-0.24
    Revenue Consensus
    $4M
    Range$4M - $5M
    2 analysts
    Dec 31, 2026
    EPS Consensus$-0.29
    Range$-0.30 - $-0.28
    2 analysts
    Revenue Consensus
    $5M
    Range$4M - $5M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.29---
    Sep 26EST
    		-$-0.24---
    Jun 26
    		$-0.31$-0.27-14.81%Miss+6.1%
    Mar 26
    		$-0.30$-0.29-3.45%Miss+11.8%
    Dec 25
    		$-0.29$-0.31+6.45%Beat+21.6%
    Sep 25
    		$-0.32$-0.30-6.67%Miss+8.6%
    Jun 25
    		$-0.33$-0.37+10.81%Beat+5.7%
    Mar 25
    		$-0.34$-0.36+5.56%Beat-6.3%
    Dec 24
    		$-0.37$-0.39+4.42%Beat-32.1%
    Sep 24
    		$-0.35$-0.31-12.90%Miss-6.1%
    Jun 24
    		$-0.35$-0.36+2.78%Beat+5.4%
    Mar 24
    		$-0.32$-0.30-6.67%Miss+15.8%
    Dec 23
    		$-0.28$-0.37+24.32%Beat+22.2%
    Sep 23
    		$-0.33$-0.40+17.50%Beat+13.2%
    Jun 23
    		$-0.37$-0.40+7.50%Beat+0.0%
    Mar 23
    		$-0.38$-0.38+0.00%Beat+0.0%
    Dec 22
    		$-0.36$-0.43+16.28%Beat-12.5%
    Sep 22
    		$-0.38$-0.39+2.56%Beat-26.7%
    Jun 22
    		$-0.37$-0.39+5.13%Beat-37.0%
    Mar 22
    		$-0.38$-0.39+2.56%Beat-40.7%
    Dec 21
    		$-0.32$-0.32+0.00%Beat+40.7%
    Sep 21
    		$-0.30$-0.29-3.45%Miss-150.0%
    Jun 21
    		$-0.27$-0.28+3.57%Beat-350.0%
    Mar 21
    		$-0.27$-0.20-35.00%Miss+57.0%
    Dec 20
    		$-0.54$-0.48-12.50%Miss-
    Sep 20
    		$-0.12N/A+83.56%Beat-
    Jun 20
    		$-0.06$0.00N/AMiss-
    Sep 19
    		$-0.63$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-1.61EV/EBITDA1.72x
    Price/FCF-2.44xFCF Yield-40.91%
    Profitability
    Profit Margin0.00%Operating Margin-543.00%
    ROE-26.50%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio14.74xQuick Ratio14.06x
    Trading Statistics
    Beta1.52Avg Volume239.62K
    52-Week High$2.4152-Week Low$1.55

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.02
    SMA 20$2.08
    SMA 50$2.03
    SMA 200$1.90
    EMA 10$2.02
    EMA 20$2.05
    EMA 50$2.02
    EMA 200$1.96

    MACD

    Line: -0.02Signal: -0.00Hist: -0.02

    ADX

    ADX: 11.1+DI: 19.2-DI: 25.8

    Aroon & PSAR

    Aroon Up16.0
    Aroon DownN/A
    PSAR$2.33

    Bollinger Bands

    Upper Band$2.24
    Lower Band$1.92
    %B Position1497%(Upper)
    Band Width0.11

    RSI (14-Day)

    Neutral
    37.5

    Momentum Oscillators

    Stoch %K2.7
    Stoch %D6.0
    Williams %R-96.3
    ROC (10d)-3.4%
    Momentum-0.07
    CCI (20d)-116.1
    MFI (14d)33.9

    Volatility Measures

    ATR (14d)$0.06(3.3%)
    StdDev (20d)0.08
    Hist Vol14.3%(Low)

    Volume Flow

    VWAP$1.97
    OBV15.4M
    AD Line-16.4M
    CMF (20d)-0.228

    Volume Metrics

    Avg Vol (20d)224.9K
    Vol Ratio0.6x
    VWMA (20d)$2.10

    Pivot Points

    R3$2.04
    R2$2.03
    R1$2.01
    Pivot Point$1.99
    S1$1.97
    S2$1.95
    S3$1.93

    Advanced Oscillators

    TSI-9.15
    Ultimate Osc35.0
    KST-18.24

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$3.10M$2.79M$4.20M$4.12M$4.05M$4.21M$4.00M$4.03M$3.07M$3.07M$4.44M$4.16M
    Cost of Revenue$1.60M$1.81M$2.02M$2.01M$1.94M$2.14M$1.98M$2.09M$1.34M$1.71M$2.44M$2.01M
    Gross Profit$1.51M$982,000$2.18M$2.11M$2.11M$2.06M$2.02M$1.94M$1.73M$1.36M$2.00M$2.16M
    Operating Expenses$18.35M$18.24M$19.57M$21.46M$22.64M$22.79M$25.51M$26.26M$28.83M$26.55M$24.23M$28.00M
    R&D$8.21M$8.81M$9.74M$10.80M$11.98M$11.35M$12.62M$12.97M$12.73M$12.27M$11.16M$13.23M
    SG&A$10.14M$9.43M$9.83M$10.66M$10.66M$11.44M$12.89M$13.30M$16.09M$14.29M$13.07M$14.77M
    Operating Income$-16,841,000$-17,256,000$-17,385,000$-19,346,000$-20,530,000$-20,731,000$-23,488,000$-24,325,000$-27,096,000$-25,192,000$-22,232,000$-25,845,000
    Interest Income$-36,000$497,000$1.46M$1.35M$1.15M$1.64M$1.78M$3.22M$4.43M$4.59M$4.72M$4.77M
    Interest Expense$49,000$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-16,890,000$-16,827,000$-15,966,000$-18,210,000$-19,376,000$-19,847,000$-21,644,000$-21,328,000$-22,850,000$-20,679,000$-17,799,000$-21,088,000
    Income Tax Expense$9,000$10,000$28,000$24,000$48,000$101,000$98,000$0$0$0$0$0
    Net Income$-16,899,000$-16,837,000$-15,994,000$-18,234,000$-19,424,000$-19,948,000$-21,742,000$-21,328,000$-22,850,000$-20,679,000$-17,799,000$-21,088,000
    EBITDA$-15,641,000$-15,030,000$-16,248,000$-17,456,000$-19,266,000$-18,787,000$-21,319,000$-22,372,000$-26,178,000$-21,420,000$-23,942,000$-27,564,000
    EBIT$-16,854,000$-17,324,000$-17,430,000$-19,556,000$-20,527,000$-21,489,000$-23,421,000$-24,549,000$-27,283,000$-25,265,000$-22,519,000$-25,855,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SEER

    Government Contracts

    Gov Obligations (TTM)
    $56000
    Gov Obligations / Revenue
    0.4%
    Obligations YoY
    -95.0%
    Active Awards
    1
    New Awards (TTM)
    1
    Avg Remaining Term
    10.2 mo

    Top agency: Department of Health and Human Services at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75N98026P00731Department of Health and Human ServicesNational Institutes of Health$56000Jun 10, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Seer president & CFO David Horn sells $14,809 in company stock

    Seer's President & CFO, David R. Horn, sold 7,309 shares of the company's Class A Common Stock for $14,809 to cover tax obligations from vested restricted stock units. This transaction occurred on August 18, 2026, leaving Mr. Horn with 486,650 shares. The sale follows Seer's recent financial report for Q2 2026, which showed a wider-than-expected loss and lower-than-forecasted revenue, highlighting ongoing profitability challenges for the company.

    Investing.com•8/20/26•
    Bearish

    Weekly Recap: Buyout bids for SEER and Disclosure probe into SEER

    Seer, Inc. (NASDAQ:SEER) has received two unsolicited buyout proposals: one from Radoff–JEC for $2.55 cash plus a CVR, and another from CEO Omid Farokhzad for $2.45 cash plus two long-dated CVRs. Concurrently, a law firm has initiated an investigation into potential disclosure failures by SEER that may have negatively impacted shareholders.

    TradingView•8/3/26•
    Somewhat-Bearish

    Seer to Report Second Quarter 2026 Financial Results on August 11, 2026

    Seer, Inc. announced it will report its second-quarter 2026 financial results on Tuesday, August 11, 2026. Company management will host a webcast conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results, with live audio and an archived replay available on the investor section of Seer’s website. Seer is a pioneer in deep, unbiased proteomics, offering the Proteograph Product Suite for research purposes.

    Sahm•8/3/26•
    Neutral

    Seer Inc. (Nasdaq: SEER) CEO offers $2.45 cash plus CVRs in buyout

    Seer Inc. CEO Omid Farokhzad has submitted a non-binding proposal to take the company private, offering $2.45 per share in cash plus two contingent value rights (CVRs). The cash portion represents a 41% premium to Seer’s 30-day volume-weighted average price, with potential for up to a 222% premium if both CVRs fully pay out based on future revenue milestones and strategic transactions. The proposal, which is not subject to financing, will be evaluated by a Special Committee of Seer's independent directors, and stockholders are advised that no action is required at this time.

    Stock Titan•8/1/26•
    Somewhat-Bullish

    Revised $2.45 and $2.55 per-share bids emerge for Seer (NASDAQ: SEER)

    Seer, Inc. (NASDAQ: SEER) has received two revised, non-binding acquisition proposals: one from the Radoff-JEC Group for $2.55 per share plus a CVR, and another from CEO Omid Farokhzad for $2.45 per share plus two CVRs. Farokhzad's offer could reach up to $7.69 per share with contingent value rights tied to 2033 revenue milestones and future transaction value, representing significant premiums over the 30-day volume-weighted average price. A Special Committee of Seer's Board will review both proposals and other alternatives, with no immediate stockholder action required.

    Stock Titan•8/1/26•
    Somewhat-Bullish

    Frequently Asked Questions About SEER

    Does SEER pay dividends?
    Seer Inc (SEER) does not currently pay a regular dividend.
    What is SEER's market cap?
    Seer Inc (SEER) has a market capitalization of $109.64M with a current stock price of $1.96.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In